In vitro and in vivo assessment of CdTe and CdHgTe toxicity and clearance

Li Liu, Jun Zhang, Xing Su, Ralph P. Mason

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Semiconductor QDs are being developed as fluorescent tags for biomedical applications such as imaging, targeting, therapeutic carriers, drug delivery, nanomedicine, and in vitro and in vivo biological labeling. However, potential toxicity and clearance of semiconductor QDs in biological systems are of concern. We have tested toxicity and clearance in vitro and in vivo (subcutaneous) of CdTe and CdHgTe semiconductor QDs in human breast cancer MCF7 and MBA-MD-231 cells and prostate cancer PC3 cells over a period of 40 days. Our results show that both CdTe and CdHgTe QDs are cytotoxic to human breast and prostate cancer cells. CdHgTe ODs were cleared rapidly from the site of injection, while CdTe were still detectable 18 days after injection, but were cleared by 30 days.

Original languageEnglish (US)
Pages (from-to)524-528
Number of pages5
JournalJournal of Biomedical Nanotechnology
Volume4
Issue number4
DOIs
StatePublished - Dec 2008

Fingerprint

Semiconductors
Toxicity
Semiconductor materials
Prostatic Neoplasms
Breast Neoplasms
Nanomedicine
Medical nanotechnology
Injections
Drug Carriers
Biological systems
Drug delivery
Labeling
Cells
Imaging techniques
mercury cadmium telluride
In Vitro Techniques
Therapeutics

Keywords

  • CdHgTe
  • CdTe
  • Clearance
  • Semiconductor QDs
  • Toxicity

ASJC Scopus subject areas

  • Materials Science(all)
  • Bioengineering
  • Biomedical Engineering
  • Medicine (miscellaneous)
  • Pharmaceutical Science

Cite this

In vitro and in vivo assessment of CdTe and CdHgTe toxicity and clearance. / Liu, Li; Zhang, Jun; Su, Xing; Mason, Ralph P.

In: Journal of Biomedical Nanotechnology, Vol. 4, No. 4, 12.2008, p. 524-528.

Research output: Contribution to journalArticle

@article{580679e0eb5a4cabb580c9f5ce273cbf,
title = "In vitro and in vivo assessment of CdTe and CdHgTe toxicity and clearance",
abstract = "Semiconductor QDs are being developed as fluorescent tags for biomedical applications such as imaging, targeting, therapeutic carriers, drug delivery, nanomedicine, and in vitro and in vivo biological labeling. However, potential toxicity and clearance of semiconductor QDs in biological systems are of concern. We have tested toxicity and clearance in vitro and in vivo (subcutaneous) of CdTe and CdHgTe semiconductor QDs in human breast cancer MCF7 and MBA-MD-231 cells and prostate cancer PC3 cells over a period of 40 days. Our results show that both CdTe and CdHgTe QDs are cytotoxic to human breast and prostate cancer cells. CdHgTe ODs were cleared rapidly from the site of injection, while CdTe were still detectable 18 days after injection, but were cleared by 30 days.",
keywords = "CdHgTe, CdTe, Clearance, Semiconductor QDs, Toxicity",
author = "Li Liu and Jun Zhang and Xing Su and Mason, {Ralph P.}",
year = "2008",
month = "12",
doi = "10.1166/jbn.2008.018",
language = "English (US)",
volume = "4",
pages = "524--528",
journal = "Journal of Biomedical Nanotechnology",
issn = "1550-7033",
publisher = "American Scientific Publishers",
number = "4",

}

TY - JOUR

T1 - In vitro and in vivo assessment of CdTe and CdHgTe toxicity and clearance

AU - Liu, Li

AU - Zhang, Jun

AU - Su, Xing

AU - Mason, Ralph P.

PY - 2008/12

Y1 - 2008/12

N2 - Semiconductor QDs are being developed as fluorescent tags for biomedical applications such as imaging, targeting, therapeutic carriers, drug delivery, nanomedicine, and in vitro and in vivo biological labeling. However, potential toxicity and clearance of semiconductor QDs in biological systems are of concern. We have tested toxicity and clearance in vitro and in vivo (subcutaneous) of CdTe and CdHgTe semiconductor QDs in human breast cancer MCF7 and MBA-MD-231 cells and prostate cancer PC3 cells over a period of 40 days. Our results show that both CdTe and CdHgTe QDs are cytotoxic to human breast and prostate cancer cells. CdHgTe ODs were cleared rapidly from the site of injection, while CdTe were still detectable 18 days after injection, but were cleared by 30 days.

AB - Semiconductor QDs are being developed as fluorescent tags for biomedical applications such as imaging, targeting, therapeutic carriers, drug delivery, nanomedicine, and in vitro and in vivo biological labeling. However, potential toxicity and clearance of semiconductor QDs in biological systems are of concern. We have tested toxicity and clearance in vitro and in vivo (subcutaneous) of CdTe and CdHgTe semiconductor QDs in human breast cancer MCF7 and MBA-MD-231 cells and prostate cancer PC3 cells over a period of 40 days. Our results show that both CdTe and CdHgTe QDs are cytotoxic to human breast and prostate cancer cells. CdHgTe ODs were cleared rapidly from the site of injection, while CdTe were still detectable 18 days after injection, but were cleared by 30 days.

KW - CdHgTe

KW - CdTe

KW - Clearance

KW - Semiconductor QDs

KW - Toxicity

UR - http://www.scopus.com/inward/record.url?scp=58149354525&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149354525&partnerID=8YFLogxK

U2 - 10.1166/jbn.2008.018

DO - 10.1166/jbn.2008.018

M3 - Article

VL - 4

SP - 524

EP - 528

JO - Journal of Biomedical Nanotechnology

JF - Journal of Biomedical Nanotechnology

SN - 1550-7033

IS - 4

ER -